Reuters logo
2 months ago
BRIEF-Essex Bio-Technology announces approval to commercialise Tobramycin eye drops in China
June 13, 2017 / 10:35 AM / 2 months ago

BRIEF-Essex Bio-Technology announces approval to commercialise Tobramycin eye drops in China

June 13 (Reuters) - Essex Bio-technology Ltd :

* Announces approval to commercialise preservative-free single-dose Tobramycin eye drops in China

* Approved product is expected to be launched in market at or around end of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below